- Hardcover: 1814 pages
- Publisher: Wiley-VCH; 1 edition (April 9, 2007)
- Language: English
- ISBN-10: 3527312781
- ISBN-13: 978-3527312788
- Product Dimensions: 7 x 4.2 x 9.7 inches
- Shipping Weight: 8.4 pounds (View shipping rates and policies)
- Average Customer Review: Be the first to review this item
- Amazon Best Sellers Rank: #15,406,629 in Books (See Top 100 in Books)
Enter your mobile number or email address below and we'll send you a link to download the free Kindle App. Then you can start reading Kindle books on your smartphone, tablet, or computer - no Kindle device required.
To get the free app, enter your mobile phone number.
Bioinformatics: From Genomes to Therapies (3 Volume Set) (v. 1-3) 1st Edition
Use the Amazon App to scan ISBNs and compare prices.
"Enlightenment Now: The Case for Reason, Science, Humanism, and Progress"
Is the world really falling apart? Is the ideal of progress obsolete? Cognitive scientist and public intellectual Steven Pinker urges us to step back from the gory headlines and prophecies of doom, and instead, follow the data: In seventy-five jaw-dropping graphs, Pinker shows that life, health, prosperity, safety, peace, knowledge, and happiness are on the rise. Learn more
"This treatise on bioinformatics is an excellent reference set to use as additional reading in advanced undergraduate and graduate courses"
From the Back Cover
Once again, Thomas Lengauer has succeeded in creating a comprehensive and immensely useful resource that meets even the high standards of professionals in the pharmaceutical and medical sector.
By extending the classical application areas of bioinformatics to the latest approaches in analyzing molecular networks and predicting molecular function, this handbook serves as a one-stop resource for every bioinformatics user in the life and medical sciences. With contributions by more than 80 of the world's leading bioinformaticians, it is unrivalled in terms of both scientific authority and accuracy. Its coverage extends beyond the biological background and methodological basics to include such topical aspects as the optimization of drug leads, personalization of drug therapies, and disease-specific applications, such as bacterial or viral infections, supported by numerous references to bioinformatics software and data resources throughout.
The best single information source available - written by professionals for professionals.
Thomas Lengauer is Director of the Max-Planck Institute for Informatics in Saarbrucken, Germany. He has been involved in computational biology research since the beginning of the 1990s, focusing on protein bioinformatics, computational drug screening and design, as well as bioinformatics for understanding and curing diseases. He is a founding member of the International Society for Computational Biology (ISCB), a member of the steering board of the international conference series RECOMB, and headed the steering board of the European bioinformatics conference series ECCB since its foundation in 2002 until 2005. In 2001 he co-founded BioSolveIT GmbH, which develops and distributes chemoinformatics software. A member of the German Academy of Sciences Leopoldina, in 2003 Professor Lengauer received the Konrad Zuse Medal of the German Informatics Society and the Karl Heinz Beckurts Award.
|5 star (0%)|
|4 star (0%)|
|3 star (0%)|
|2 star (0%)|
|1 star (0%)|